Evercore ISI Upgrades Neurocrine Bio. (NBIX) to Outperform, 'We believe 2023 Ingrezza guidance will prove to be conservative'
Tweet Send to a Friend
(Updated - March 3, 2023 6:32 AM EST)
Evercore ISI analyst Josh Schimmer upgraded Neurocrine Bio. (NASDAQ: NBIX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Evercore ISI analyst Josh Schimmer upgraded Neurocrine Bio. (NASDAQ: NBIX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
